Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraPsil is a Canadian nonprofit focused on expanding legal, compassionate access to psychedelic-assisted psychotherapy and building a trusted ecosystem for psychedelic healthcare. The organization provides clinician training in psilocybin- and MDMA-assisted psychotherapy, patient navigation and legal support, advocacy related to Health Canada access pathways, and collaborative research initiatives. TheraPsil has been particularly active in palliative and end-of-life care, while also expanding into broader mental health and wellness applications. Its offerings include a national practitioner directory, professional education programs, and support for clinical research such as the PsilWell wellness-focused psychedelic therapy study.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraPsil.